All
Incidence of Early-Onset Liver Cancer in Younger Patients Decreasing
The incidence of hepatocellular carcinoma has risen between 2010 and 2019; however, for people under 50 years of age, the proportion of cases has declined.
Epkinly Combo Reduces Risk of Progression or Death in Follicular Lymphoma
Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.
How Biomarkers May Help Guide Kidney Cancer Treatment Earlier
Dr. Wenxin (Vincent) Xu discussed the benefit of using biomarkers to more precisely guide treatment for patients with renal cell carcinoma.
Please Don’t Call Me ‘Dear’: A Poem From Cancer Treatment
I wrote a poem about life with endometrial cancer, rejecting pity and embracing strength, connection and the dignity of being truly seen.
Survivorship Anxiety: What Comes After Cancer Treatment
CURE spoke with an expert about specific psychological concerns faced by cancer survivors.
Mom Supports Other Parents After Daughter’s Bone Cancer Diagnosis
Dena Paluck became a mentor to other parents after guiding her daughter through osteosarcoma treatment and feeling isolated during the process.
A Letter to My Support System
I survived peritoneal mesothelioma thanks to the love, prayers, and support of family, friends, and strangers who reminded me I was never alone.
Zusduri Shows Durable Response in Non–Muscle-Invasive Bladder Cancer
In a phase 3 trial, 72.2% of patients with recurrent low-grade bladder cancer kept complete response at 24 months after Zusduri treatment.
AI May Better Predict Cancer Biomarkers and Patient Survival
An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.
The Importance of Expert Opinions After a GIST Diagnosis
Getting an expert opinion is essential after a rare cancer diagnosis like GIST, as each patient’s situation is unique, according to Dr. Weijing Sun.
Survivor Builds Support Network for Women With Cancer
Staci Kirk, a six-time cancer survivor, founded the Stiletto Boss Foundation to empower women through mentorship, self-advocacy and healing.
Finishing Chemo with Stage 4 Lung Cancer: Facing Hope and Uncertainty
In an interview with CURE, Clara Cirk shares the emotional weight of finishing chemo while facing ongoing immunotherapy and the uncertainty it brings.
FDA Approves Modeyso for Patients with Diffuse Midline Glioma
The U.S. FDA granted accelerated approval to Modeyso for patients with diffuse midline glioma with an H3 K27M mutation with progressive disease.
Expert Oncologist Breaks Down Newest FDA Approval in Lung Cancer
Following the June 2025 FDA approval of Datroway, Dr. Jacob A. Sands explained the significance of the regulatory approval for patients with lung cancer.
Shaved Heads and Shared Tears: How My Sister Helped Me Face Cancer
During my breast cancer journey, my sister Kelly’s love and support — especially the day she shaved my head — gave me strength, comfort, and control.
FDA Accepts Breyanzi sBLA for Relapsed Marginal Zone Lymphoma
The FDA accepted a supplemental application for Breyanzi to treat adults with relapsed or refractory marginal zone lymphoma after two prior therapies.
How Physical Activity Impacts Cancer Care Outcomes
LaShae D. Rolle discusses how maintaining physical activity during active breast cancer treatment may impact a patients mental and emotional well-being.
A Letter to My Children Who Loved Their Sister Through Cancer
When my daughter had cancer, my other children carried our family with grace, compassion and strength I didn’t know I’d one day need from them.
JAK Inhibitors May Reverse Immunotherapy-Induced Diabetes
Existing autoimmune drugs may prevent or reverse a serious side effect faced by patients with cancer.
What Can Influence Immunotherapy Responses in Kidney Cancer?
TAMs may help predict response to PD-1 inhibitors in metastatic clear cell kidney cancer, Dr. Berkay Simsek reported at the 2025 Kidney Cancer Summit.
Emerging from Isolation After Cancer Reaped Many Rewards
After my cancer diagnosis, I planned to go it alone but found unconditional acceptance from the cancer community once I took the first step.
Guiding Patients With Metastatic Breast Cancer on Treatment Choices
An expert helps patients with metastatic breast cancer understand treatment sequencing, biomarker testing and emerging options to support decision-making.
First Patient With Breast Cancer Dosed With Novel Radioactive Medicine
The first patient in the U.S. has been dosed with a novel radioactive medicine to treat advanced breast cancer as part of an international clinical trial.
How Do Antibody-Drug Conjugates Work in Lung Cancer?
Dr. Jacob A. Sands shares how antibody-drug conjugates, such as Datroway, work to selectively target and destroy tumor cells among those with lung cancer.
Finding Cancer Healing Through Creativity and Human Connection
After joining a creative survivors’ group, I discovered that emotional expression, art and connection offered a profound kind of healing beyond treatment.
TikTok Creator Breaks Stigma Around Male Breast Cancer
Jake Messier uses TikTok to raise awareness about male breast cancer, calling out stigma and isolation that delay diagnosis and harm treatment outcomes.
Men Can Get Breast Cancer Too
Jake Messier uses TikTok to raise awareness about male breast cancer, advocate for inclusivity and foster community after his stage 4 diagnosis.
Finishing Cancer Treatment Didn’t Bring the Relief You’d Expect
When treatment ended, people expected relief, but what I felt was loss, fear, and the weight of a life forever changed.
Treating EHE: What Are Your Options?
Treatment options for patients with epithelioid hemangioendothelioma vary dependent on disease status, but more therapies are under investigation.
FDA Approves Application for ABT-301 in Metastatic Colorectal Cancer
The FDA approved an investigational new drug application for ABT-301, clearing the way for a new clinical trial in metastatic colorectal cancer to begin.
